Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Minerva Endocrinology is Scopus-indexed (Q2, CiteScore 4.3), WoS SCIE. Published by Edizioni Minerva Medica.
Checked against the index lists dated .
ISSN 2724-6116Verify ISSN ↗2724-6507Verify ISSN ↗
Publisher: Edizioni Minerva Medica
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Internal Medicine | 68 / 179 | 62nd | Q2 |
| Endocrinology, Diabetes and Metabolism | 125 / 250 | 50th | Q2 |
| Endocrinology | 80 / 132 | 39th | Q3 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2021–present, best quartile Q2, CiteScore 4.3.
Minerva Endocrinology is Q2 in Internal Medicine (rank 68 of 179), Q2 in Endocrinology, Diabetes and Metabolism (rank 125 of 250) and Q3 in Endocrinology (rank 80 of 132), by CiteScore 2025.
Minerva Endocrinology is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 4.3, which places it in quartile Q2 at the 62nd percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.496, quartile Q3, with an H-index of 45.
Minerva Endocrinology is published by Edizioni Minerva Medica. Its print ISSN is 2724-6116 and its online ISSN is 2724-6507.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Minerva Endocrinology has an h-index of 28 and a 2-year mean of 2.47 citations per paper (OpenAlex). Its Scopus CiteScore is 4.3, quartile Q2. On 2-year citations it ranks #55 of 172 Scopus journals in Internal Medicine.
Minerva Endocrinology published 35 papers in 2025; its busiest recent year was 2021 with 128. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 100 research articles (2023–2026), authors are most often from Italy (51.7%), China (8%) and Portugal (5%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.